CIPRO XR Drug Patent Profile

✉ Email this page to a colleague

When do Cipro Xr patents expire, and what generic alternatives are available?

Cipro Xr is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in CIPRO XR is ciprofloxacin; ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Additional details are available on the ciprofloxacin; ciprofloxacin hydrochloride profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CIPRO XR?
What are the global sales for CIPRO XR?
What is Average Wholesale Price for CIPRO XR?

Summary for CIPRO XR

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	123
Drug Prices:	Drug price information for CIPRO XR
DailyMed Link:	CIPRO XR at DailyMed

Drug patent expirations by year for CIPRO XR

US Patents and Regulatory Information for CIPRO XR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Hlthcare	CIPRO XR	ciprofloxacin; ciprofloxacin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021473-001	Dec 13, 2002		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bayer Hlthcare	CIPRO XR	ciprofloxacin; ciprofloxacin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021473-002	Aug 28, 2003		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CIPRO XR

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Hlthcare	CIPRO XR	ciprofloxacin; ciprofloxacin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021473-001	Dec 13, 2002	⤷ Sign Up	⤷ Sign Up
Bayer Hlthcare	CIPRO XR	ciprofloxacin; ciprofloxacin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021473-002	Aug 28, 2003	⤷ Sign Up	⤷ Sign Up
Bayer Hlthcare	CIPRO XR	ciprofloxacin; ciprofloxacin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021473-002	Aug 28, 2003	⤷ Sign Up	⤷ Sign Up
Bayer Hlthcare	CIPRO XR	ciprofloxacin; ciprofloxacin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021473-002	Aug 28, 2003	⤷ Sign Up	⤷ Sign Up
Bayer Hlthcare	CIPRO XR	ciprofloxacin; ciprofloxacin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021473-001	Dec 13, 2002	⤷ Sign Up	⤷ Sign Up
Bayer Hlthcare	CIPRO XR	ciprofloxacin; ciprofloxacin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021473-001	Dec 13, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for CIPRO XR

See the table below for patents covering CIPRO XR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	1296685	PREPARATIONS A LIBERATION PROLONGEE A BASE D'ANTIBIOTIQUES DE TYPE QUINOLONES ET PROCEDE D'ELABORATION DESDITES PREPARATIONS (SUSTAINED-RELEASE PREPARATIONS OF QUINOLONE ANTIBIOTICS AND METHOD FOR PREPARATION THEREOF)	⤷ Sign Up
Poland	360632		⤷ Sign Up
Australia	7468081		⤷ Sign Up
Japan	S5777683	7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO- NAPHTHYRIDINE-3-CARBOXYLIC ACIDS OR SALTS THEREOF, MANUFACTURE AND ANTIBACTERIAL THEREOF AS ACTIVE INGREDIENT	⤷ Sign Up
Peru	20020207	PREPARACIONES DE LIBERACION CONTROLADA QUE COMPRENDEN DERIVADOS DE QUINOLONA Y POLIMEROS	⤷ Sign Up
Hong Kong	1058479		⤷ Sign Up
Estonia	200200707		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for CIPRO XR

Make Better Decisions: Try a trial or see plans & pricing